SERA PROGNOSTICS, INC. Paid-in-Kind Interest
SERA PROGNOSTICS, INC. (SERA) reported Paid-in-Kind Interest of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Cash Flow
us-gaap:PaidInKindInterest · last filed 2024-03-20
- SERA PROGNOSTICS, INC. paid-in-kind interest for the quarter ending 2023-12-31 was $0.00.
- SERA PROGNOSTICS, INC. paid-in-kind interest for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- SERA PROGNOSTICS, INC. paid-in-kind interest for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- SERA PROGNOSTICS, INC. paid-in-kind interest for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- SERA PROGNOSTICS, INC. paid-in-kind interest for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- SERA PROGNOSTICS, INC. paid-in-kind interest for fiscal 2022 was $12.00K, a 97.96% decline from fiscal 2021.
- SERA PROGNOSTICS, INC. paid-in-kind interest for fiscal 2021 was $588.00K, a 63.00% decline from fiscal 2020.
- SERA PROGNOSTICS, INC. paid-in-kind interest for fiscal 2020 was $1.59M.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $0.00 derived: sum of 2 quarters · filed 2024-03-20 | $0.00 derived: sum of 3 quarters · filed 2024-03-20 | $0.00 10-K · filed 2024-03-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2024-03-20 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-03-20 | $3.00K derived: sum of 4 quarters · filed 2024-03-20 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-03-20 | $3.00K derived: sum of 3 quarters · filed 2024-03-20 | $10.00K derived: sum of 4 quarters · filed 2024-03-20 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $3.00K derived: sum of 2 quarters · filed 2024-03-20 | $10.00K derived: sum of 3 quarters · filed 2024-03-20 | $12.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $10.00K derived: sum of 2 quarters · filed 2023-11-08 | $12.00K 10-Q · filed 2023-11-08 | $12.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $9.00K 10-Q · filed 2023-08-09 | $9.00K derived: sum of 3 quarters · filed 2023-08-09 | $439.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-10 | $2.00K derived: sum of 2 quarters · filed 2023-05-10 | $432.00K derived: sum of 3 quarters · filed 2023-05-10 | $422.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $430.00K derived: sum of 2 quarters · filed 2023-03-22 | $420.00K derived: sum of 3 quarters · filed 2023-03-22 | $588.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $420.00K derived: sum of 2 quarters · filed 2022-11-09 | $588.00K 10-Q · filed 2022-11-09 | $1.10M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $158.00K 10-Q · filed 2022-08-10 | $671.00K derived: sum of 3 quarters · filed 2022-08-10 | $1.04M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $168.00K 10-Q · filed 2022-05-10 | $681.00K derived: sum of 2 quarters · filed 2022-05-10 | $1.05M derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $513.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $882.00K derived: sum of 2 quarters · filed 2022-03-29 | $1.59M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $369.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.08M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $707.00K 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |